Influence of Key Monitoring Drugs Policy on the Change of Adjuvant Drugs in Sample Area

LIANG Guang-kai, FU Yu, LI Jun-lei, QIN Si-bei, YI Xin, GUAN Xiao-dong, SHAO Hong, NIE Xiao-yan, SHI Lu-wen

Chinese Pharmaceutical Journal ›› 2018, Vol. 53 ›› Issue (18) : 1613-1619.

PDF(1962 KB)
PDF(1962 KB)
Chinese Pharmaceutical Journal ›› 2018, Vol. 53 ›› Issue (18) : 1613-1619. DOI: 10.11669/cpj.2018.18.017

Influence of Key Monitoring Drugs Policy on the Change of Adjuvant Drugs in Sample Area

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2018, 53(18): 1613-1619 https://doi.org/10.11669/cpj.2018.18.017

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1962 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉